Zheng YQ - Search Results

1

[The clinical study on neoadjuvant chemotherapy with combination of docetaxel and pharmorubicin for locally advanced breast cancer].

Li XR, Ma B, Wang JD, Liu HY, Li J, Zheng YQ, Zhang YJ, Chen YQ, Jin YC, Li R. Li XR, et al. Among authors: zheng yq. Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):85-7. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18353209 Chinese.

2

The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.

Wang X, Yang Z, Zhang H, Ding L, Li X, Zhu C, Zheng Y, Ye Q. Wang X, et al. Biochim Biophys Acta. 2008 Jun;1783(6):1220-8. doi: 10.1016/j.bbamcr.2008.01.026. Epub 2008 Feb 12. Biochim Biophys Acta. 2008. PMID: 18302941 Free article.

3

[Effects of neoadjuvant chemotherapy of docetaxel combined with and epirubicin or pirarubicin on breast cancer: clinical analysis of 160 cases].

Li XR, Wang JD, Zhang YJ, Kong QL, Ma B, Li J, Zheng YQ, Chen YQ, Jin YC, Li R. Li XR, et al. Among authors: zheng yq. Zhonghua Yi Xue Za Zhi. 2009 Jan 13;89(2):87-90. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19489268 Chinese.

4

FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.

Ding L, Niu C, Zheng Y, Xiong Z, Liu Y, Lin J, Sun H, Huang K, Yang W, Li X, Ye Q. Ding L, et al. J Cell Mol Med. 2011 Jan;15(1):72-85. doi: 10.1111/j.1582-4934.2009.00938.x. J Cell Mol Med. 2011. PMID: 19840196 Free PMC article.

5

Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer.

Li XR, Liu M, Zhang YJ, Wang JD, Zheng YQ, Li J, Ma B, Song X. Li XR, et al. Among authors: zheng yq. Med Oncol. 2011 Dec;28 Suppl 1:S31-8. doi: 10.1007/s12032-010-9676-z. Epub 2010 Sep 16. Med Oncol. 2011. PMID: 20844986

6

ER, PgR, HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer.

Li XR, Liu M, Zhang YJ, Wang JD, Zheng YQ, Li J, Ma B, Song X. Li XR, et al. Among authors: zheng yq. Med Oncol. 2011 Dec;28 Suppl 1:S48-54. doi: 10.1007/s12032-010-9693-y. Epub 2010 Sep 25. Med Oncol. 2011. PMID: 20872186

7

CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients.

Li XR, Liu M, Zhang YJ, Wang JD, Zheng YQ, Li J, Ma B, Song X. Li XR, et al. Among authors: zheng yq. Med Oncol. 2011 Dec;28 Suppl 1:S129-34. doi: 10.1007/s12032-010-9742-6. Epub 2010 Nov 16. Med Oncol. 2011. PMID: 21080107

8

[Study on diagnostic accuracy of ultrasound-guided core needle breast biopsy].

Liu M, Chen W, Li XR, Li JL, Wang JD, Zhang YJ, Zheng YQ, Wei LX. Liu M, et al. Among authors: zheng yq. Zhonghua Bing Li Xue Za Zhi. 2010 Nov;39(11):739-42. Zhonghua Bing Li Xue Za Zhi. 2010. PMID: 21215163 Chinese.

9

DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.

Li XR, Cheng LQ, Liu M, Zhang YJ, Wang JD, Zhang AL, Song X, Li J, Zheng YQ, Liu L. Li XR, et al. Among authors: zheng yq. Med Oncol. 2012 Jun;29(2):425-31. doi: 10.1007/s12032-011-9842-y. Epub 2011 Feb 1. Med Oncol. 2012. PMID: 21286861

10

Intraoperative radiotherapy in patients with breast cancer treated by breast-conserving therapy.

Zhang YJ, Liu L, Ma L, Yu W, Liu M, Cheng LQ, Li J, Zheng YQ, Wang JD, Kong QL, Li XR. Zhang YJ, et al. Among authors: zheng yq. Tumori. 2012 Nov;98(6):736-42. doi: 10.1177/030089161209800610. Tumori. 2012. PMID: 23389360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters